Skip to content

Galileo Life Sciences, Inc.

CIK 0001497165

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q3 Mar 2016
Net Income (TTM)
−$1.17M
−371.9% YoY Q3 Mar 2016
EPS Diluted (TTM)
—
Q3 Mar 2016
Gross Margin
—
Q3 Mar 2016
Operating Margin
—
Q3 Mar 2016
Net Margin
—
Q3 Mar 2016
Free Cash Flow (TTM)
−$32.32K
Q3 Mar 2016
Cash
$182
Q3 Mar 2016
Total Debt
—
Q3 Mar 2016
Shares Outstanding
127.55M sh
Q3 Mar 2016

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Recent filings